Sign in
4

Changes in Ownership

Nautilus Biotechnology, Inc. Filed Acc 0001062993-22-015186

Options or other derivatives

  • Director acquired 86,467 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
PERCEPTIVE ADVISORS LLC Director 2022-06-15 Grant or award · Stock Option (Right to Buy) +86,467 86,467 I: show line 1 in the form
Loading xslF345X03/form4.xml…